Balchem (BCPC) Scheduled to Post Quarterly Earnings on Friday

Balchem (NASDAQ:BCPC) will issue its quarterly earnings data before the market opens on Friday, October 25th. Analysts expect Balchem to post earnings of $1.03 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Balchem (NASDAQ:BCPC) last announced its earnings results on Friday, July 26th. The basic materials company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.03. The firm had revenue of $234.08 million during the quarter, compared to analyst estimates of $241.26 million. Balchem had a net margin of 12.52% and a return on equity of 10.94%. On average, analysts expect Balchem to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Balchem Trading Down 0.1 %

Shares of NASDAQ:BCPC opened at $167.61 on Wednesday. The company has a 50 day moving average of $171.56 and a 200-day moving average of $162.05. The company has a current ratio of 2.83, a quick ratio of 1.79 and a debt-to-equity ratio of 0.26. The firm has a market cap of $5.43 billion, a P/E ratio of 47.35, a P/E/G ratio of 5.43 and a beta of 0.65. Balchem has a twelve month low of $110.74 and a twelve month high of $186.03.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on BCPC shares. HC Wainwright increased their price target on Balchem from $170.00 to $185.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a report on Monday, July 29th.

Insider Buying and Selling

In other Balchem news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $180.05, for a total value of $1,395,387.50. Following the transaction, the senior vice president now owns 8,540 shares of the company’s stock, valued at approximately $1,537,627. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.25% of the stock is currently owned by insiders.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.